The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapy
- 1 March 1995
- journal article
- research article
- Published by Springer Nature in Genetica
- Vol. 95 (1) , 103-109
- https://doi.org/10.1007/bf01435004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Temporal trends in the incidence of HTV‐1‐related neurologic diseasesNeurology, 1994
- Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrateThe Lancet, 1994
- HIV and AIDSScience, 1993
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Detection of Human Immunodeficiency Virus Type 1 Provirus in Mononuclear Cells by in Situ Polymerase Chain ReactionNew England Journal of Medicine, 1992
- Aids acquired by drug consumption and other noncontagious risk factorsPharmacology & Therapeutics, 1992
- Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM)AIDS, 1989
- Differential Patterns of Intracellular Metabolism of 2′,3′-Didehydro-2′,3′-dideoxythymidine and 3′-Azido-2′,3′-dideoxythymidine, Two Potent Anti-human Immunodeficiency Virus CompoundsJournal of Biological Chemistry, 1989
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986